TJP1 and type 2 diabetes mellitus: Another study in rats with type 2 diabetes (T2D) induced by HFD and low-dose streptozotocin also supports the supposition that BBR treatment significantly restores damaged intestinal mucosal structure and intestinal permeability; the reduction in tight junction protein, zonula occludens 1 (ZO1), caused by the disease was also reversed.